Page last updated: 2024-08-23

dianhydrogalactitol and etoposide

dianhydrogalactitol has been researched along with etoposide in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19904 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bauer, M; Bennett, JM; Creech, R; Hahn, RG; Wampler, G; Wolter, J1
Klastersky, J; Sculier, JP1
Arsenau, JC; Blessing, J; Lewis, GC; Slavik, M1
Creagan, ET; Eagan, RT; Kvols, LK1

Trials

1 trial(s) available for dianhydrogalactitol and etoposide

ArticleYear
Phase II study of single-agent therapy with megestrol acetate, VP-16-213, cyclophosphamide, and dianhydrogalactitol in advanced renal cell cancer.
    Cancer treatment reports, 1979, Volume: 63, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Clinical Trials as Topic; Cyclophosphamide; Dianhydrogalactitol; Drug Evaluation; Etoposide; Humans; Kidney Neoplasms; Megestrol; Middle Aged; Neoplasm Metastasis; Podophyllotoxin; Sugar Alcohols

1979

Other Studies

3 other study(ies) available for dianhydrogalactitol and etoposide

ArticleYear
Progress in chemotherapy of non-small cell lung cancer.
    European journal of cancer & clinical oncology, 1984, Volume: 20, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Dianhydrogalactitol; Doxorubicin; Drug Evaluation; Etoposide; Humans; Lung Neoplasms; Prognosis; Random Allocation; Vinblastine; Vindesine

1984
Phase II studies in advanced, recurrent pelvic malignancies: conducted by the Gynecologic Oncology Group, Experimental Design and Experience.
    American journal of clinical oncology, 1982, Volume: 5, Issue:5

    Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Dianhydrogalactitol; Drug Evaluation; Etoposide; Female; Humans; Maytansine; Neoplasm Recurrence, Local; Pelvic Neoplasms; Piperazines; Razoxane; Research Design; Triazines

1982
Preliminary study of the combination, dianhydrogalactitol, cis-diaminedichloroplatinum (II), and VP-16-213 in patients with advanced cancer.
    Oncology, 1981, Volume: 38, Issue:5

    Topics: Brain Neoplasms; Carcinoma, Squamous Cell; Cisplatin; Dianhydrogalactitol; Drug Evaluation; Drug Therapy, Combination; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Pilot Projects; Podophyllotoxin; Sugar Alcohols

1981